PTC Therapeutics, Inc. (PTCT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PTCT. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 13,964,554 | $1.1B | INCREASED |
| State Street | 4,598,952 | $375M | INCREASED |
| Pictet Asset Management Holding | 1,147,844 | $94M | DECREASED |
| Boston Partners | 718,574 | $59M | INCREASED |
| SG Americas Securities | 605,581 | $49M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Matthew B. Klein (CHIEF EXECUTIVE OFFICER) | SELL | 10,292 | $706K | 2026-08-04 |
| Hege Elisabeth Sollie-Zetlmayer (Director) | AWARD | 1,738 | $131K | 2026-07-28 |
| Hege Elisabeth Sollie-Zetlmayer (Director) | AWARD | 3,475 | $262K | 2026-07-28 |
| Hege Elisabeth Sollie-Zetlmayer (Director) | AWARD | 2,000 | 2026-07-28 | |
| Hege Elisabeth Sollie-Zetlmayer (Director) | AWARD | 4,000 | 2026-07-28 |
Full institutional holdings, insider history, and congressional trades for PTC Therapeutics, Inc. on SentiSense.